Pravin Dugel

Retina Global listed Pravin Dugel as Chairman on its 2024 Form 990.

Portrait of Pravin Dugel

Reported compensation by filing year

Each entry comes from one tax return.

  1. Tax year

    • Retina Global

      Chairman

      0.4 hours per week

      Reported total$0

      From filing organization
      $0
      From related organizations
      $0
      Other compensation
      $0

      2024 Form 990

  2. Tax year

    • Retina Global

      Chairman

      0.4 hours per week

      Reported total$0

      From filing organization
      $0
      From related organizations
      $0
      Other compensation
      $0

      2023 Form 990

  3. Tax year

    • Retina Global

      Independent Director

      0.3 hours per week

      Reported total$0

      From filing organization
      $0
      From related organizations
      $0
      Other compensation
      $0

      2022 Form 990

  4. Tax year

    • Retina Global

      Independent Director

      0.3 hours per week

      Reported total$0

      From filing organization
      $0
      From related organizations
      $0
      Other compensation
      $0

      2020 Form 990

  5. Tax year

    • Retina Global

      Independent Director

      0.3 hours per week

      Reported total$0

      From filing organization
      $0
      From related organizations
      $0
      Other compensation
      $0

      2019 Form 990

  6. Tax year

    • Retina Global

      Independent Director

      0.3 hours per week

      Reported total$0

      From filing organization
      $0
      From related organizations
      $0
      Other compensation
      $0

      2018 Form 990

Official bio

Pravin U. Dugel, MD, is a distinguished and accomplished medical professional who has achieved remarkable milestones throughout his career. Dr. Dugel's educational journey began with medicine, and further honed his expertise with medical retina and surgical retina fellowships at the Bascom Palmer Eye Institute and the USC Eye Institute, respectively. Dr. Dugel was the Managing Partner at Retinal Consultants of Arizona and a busy retina clinician until 2020. He moved to industry, joining Iveric Bio as Executive Vice President, Chief Business Officer and Chief Strategy Officer in April 2020 and later taking over the role of the President in May 2021. Iveric Bio was sold to Astellas and Dr. Dugel left the company in October 2023. Dr. Dugel's dedication to the field of ophthalmology is evident through his prolific research and scholarly work, comprising numerous published papers and book chapters. He is a sought-after speaker, having been invited to lecture at prestigious meetings, serve as a Visiting Professor, and engage with universities worldwide. His influence also extends to the editorial boards of several major medical journals. Internationally recognized as a leading clinical researcher, Dr. Dugel has played a pivotal role as a primary investigator in over 100 multicenter clinical trials. His expertise has earned him positions of distinction, including Subspecialty Day Board Chairman for the American Academy of Ophthalmology and membership on the Board of Directors of the American Society of Retina Specialists and EuRetina, Europe's largest retina society. Dr. Dugel has contributed as a member of the Scientific Advisory Board for numerous prominent companies, including Aerpio, Alcon, Digisight, Genentech, Novartis, Ophthotech, Opthea, Roche, and TrueVision. Dr. Dugel has served as President of the Phoenix Ophthalmology Society and is an active member of the Board of Directors of the Arizona Ophthalmology Society. Since 1994, he has been a dedicated member of the U.S. Furthermore, Dr. Dugel served as the Chairman of the ORBIS International Medical Advisory Board and the Medical Strategic Committee. Through his involvement with ORBIS, he has shared his expertise by traveling to developing countries, where he educates local ophthalmologists on surgical techniques and provides free surgery to individuals suffering from preventable blindness.

Official biography